ATC Group: M01AC01 Piroxicam

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AC01 in the ATC hierarchy

Level	Code	Title
`1`	M	Musculo-skeletal system
`2`	M01	Antiinflammatory and antirheumatic products
`3`	M01A	Antiinflammatory and antirheumatic products, non-steroids
`4`	M01AC	Oxicams
`5`	M01AC01	Piroxicam

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount
ORAL	Oral	20 mg
PAREN	Parenteral	20 mg
RECTAL	Rectal	20 mg

Active ingredients in M01AC01

Active Ingredient
Piroxicam
Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.

Related product monographs

Document	Type	Information Source
FELDENE Capsule, FELDENE D Tablet	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)
PIXICAM Dispersible tablet	MPI, Generic	Health Products Regulatory Authority (ZA)
PYROCAPS Capsule	MPI, Generic	Health Products Regulatory Authority (ZA)
SOTILEN Capsule	MPI, EU: SmPC	Υπουργείο Υγείας (CY)